IMP
Process View
apoptotic nuclear changes
Alterations undergone by nuclei at the molecular and morphological level as part of the execution phase of apoptosis.
Loading network...
In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "apoptotic nuclear changes"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| BCL2L1 | BCL2-like 1 | 0.889 | Human | |
| BCL2 | B-cell CLL/lymphoma 2 | 0.778 | Human | |
| CASP9 | caspase 9, apoptosis-related cysteine peptidase | 0.767 | ||
| BMPR2 | bone morphogenetic protein receptor, type II (serine/threonine kinase) | 0.695 | Human | |
| CASP3 | caspase 3, apoptosis-related cysteine peptidase | 0.438 | Mouse | |
| BAK1 | BCL2-antagonist/killer 1 | 0.399 | Human | |
| NKX2-5 | NK2 transcription factor related, locus 5 (Drosophila) | 0.321 | ||
| XIAP | X-linked inhibitor of apoptosis | 0.318 | ||
| BMP2 | bone morphogenetic protein 2 | 0.310 | ||
| POU5F1 | POU class 5 homeobox 1 | 0.272 | ||
| SYVN1 | synovial apoptosis inhibitor 1, synoviolin | 0.196 | ||
| BCL2L11 | BCL2-like 11 (apoptosis facilitator) | 0.160 | ||
| APAF1 | apoptotic peptidase activating factor 1 | 0.141 | Mouse | |
| BAX | BCL2-associated X protein | 0.121 | ||
| ZMYND11 | zinc finger, MYND-type containing 11 | 0.108 | ||
| GATA4 | GATA binding protein 4 | 0.082 | ||
| GDF5 | growth differentiation factor 5 | 0.054 | ||
| TGFB1 | transforming growth factor, beta 1 | 0.053 | ||
| RNR2 | l-rRNA | 0.049 | ||
| FKBP1A | FK506 binding protein 1A, 12kDa | 0.048 | ||
| PARP1 | poly (ADP-ribose) polymerase 1 | 0.041 | ||
| BMPR1A | bone morphogenetic protein receptor, type IA | 0.040 | Human | |
| TGFBR2 | transforming growth factor, beta receptor II (70/80kDa) | 0.039 | Human | |
| TGFB3 | transforming growth factor, beta 3 | 0.038 | ||
| VDAC1 | voltage-dependent anion channel 1 | 0.038 | ||
| ACVR1 | activin A receptor, type I | 0.038 | Human | |
| MCL1 | myeloid cell leukemia sequence 1 (BCL2-related) | 0.037 | Human | |
| C4orf14 | chromosome 4 open reading frame 14 | 0.033 | ||
| TP53 | tumor protein p53 | 0.030 | ||
| TNRC6C | trinucleotide repeat containing 6C | 0.029 | ||
| RBCK1 | RanBP-type and C3HC4-type zinc finger containing 1 | 0.026 | ||
| PRKG1 | protein kinase, cGMP-dependent, type I | 0.025 | ||
| EXOSC3 | exosome component 3 | 0.024 | ||
| SMURF2 | SMAD specific E3 ubiquitin protein ligase 2 | 0.023 | ||
| FSTL1 | follistatin-like 1 | 0.021 | ||
| NCL | nucleolin | 0.021 | ||
| MDH2 | malate dehydrogenase 2, NAD (mitochondrial) | 0.018 | ||
| PMAIP1 | phorbol-12-myristate-13-acetate-induced protein 1 | 0.018 | ||
| ENG | endoglin | 0.018 | ||
| BID | BH3 interacting domain death agonist | 0.017 | ||
| TXN2 | thioredoxin 2 | 0.017 | ||
| EIF2C1 | eukaryotic translation initiation factor 2C, 1 | 0.017 | ||
| MAPK8 | mitogen-activated protein kinase 8 | 0.016 | ||
| RNF31 | ring finger protein 31 | 0.016 | ||
| RNF144B | ring finger protein 144B | 0.015 | ||
| STOML2 | stomatin (EPB72)-like 2 | 0.015 | ||
| MYCN | v-myc myelocytomatosis viral related oncogene, neuroblastoma derived (avian) | 0.015 | ||
| AR | androgen receptor | 0.014 | ||
| PDHA1 | pyruvate dehydrogenase (lipoamide) alpha 1 | 0.014 | ||
| GOT2 | glutamic-oxaloacetic transaminase 2, mitochondrial (aspartate aminotransferase 2) | 0.013 | ||
| MRPS7 | mitochondrial ribosomal protein S7 | 0.012 | ||
| BBC3 | BCL2 binding component 3 | 0.012 | ||
| GOT1 | glutamic-oxaloacetic transaminase 1, soluble (aspartate aminotransferase 1) | 0.012 | ||
| NCAPD2 | non-SMC condensin I complex, subunit D2 | 0.012 | ||
| BAD | BCL2-associated agonist of cell death | 0.012 | ||
| FOXRED1 | FAD-dependent oxidoreductase domain containing 1 | 0.011 | ||
| NDUFS2 | NADH dehydrogenase (ubiquinone) Fe-S protein 2, 49kDa (NADH-coenzyme Q reductase) | 0.011 | ||
| DIS3 | DIS3 mitotic control homolog (S. cerevisiae) | 0.011 | ||
| EIF2C2 | eukaryotic translation initiation factor 2C, 2 | 0.011 | ||
| BIK | BCL2-interacting killer (apoptosis-inducing) | 0.011 | ||
| PRKRA | protein kinase, interferon-inducible double stranded RNA dependent activator | 0.010 | ||
| RANBP3 | RAN binding protein 3 | 0.010 |